3 Factor Indexing »

Halozyme Therapeutics shares owned by 3 Factor Indexing

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by 3 Factor Indexing from 13F filings

Historical chart of 3 Factor Indexing investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by 3 Factor Indexing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by 3 Factor Indexing

Quarter filed Position value Share count Share price at filing
2026-06-30 $157 2 78.50

More positions owned by 3 Factor Indexing

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Vanguard Bd Index Fds Short Trm Bond (BSV)
American Centy Etf Tr Us Eqt Etf (AVUS)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Dimensional Etf Trust Core Fixe In Etf (DFCF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Ultr Fix Inc Etf (DUSB)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Intl Cor Fix Etf (DFGX)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for 3 Factor Indexing

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics